GLPG5101
CP0201-NHL
Phase 2 gene_therapy active
Quick answer
GLPG5101 for Relapsed/Refractory B-cell Non-Hodgkin Lymphoma is a Phase 2 program (gene_therapy) at Lakefront Biotherapeutics NV with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lakefront Biotherapeutics NV
- Indication
- Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
- Phase
- Phase 2
- Modality
- gene_therapy
- Status
- active